fins is either a closte short or he is slowly becoming unhinged and the shelf has me concerned enough to sell 10K at $1.53...hopeuflly the ER will clarify things for my remaining balance...see yo all later
Fins has a point, you know. Antares has been making up for the revenue shortfall by selling stocks. There is nothing horrifying about this. A lot of start-ups go through this. BTW I'm not a short. Matter of fact, I see promise in Antares and am keeping an eye on the company, with a view to buying in at an appropriate time.
marketexplorer: Is looking to buy in at an appropriate time:
If not now - When ?
The stock is down 25% from a recent 52 week high. Anturol test results were great, and most are looking for a licensing agreement this year. Also Nesterone should be licensed this year. Epinephrine could be approved this year (although I think that will be in early 2011). While I don't expect a Libi-Gel license this year, we could get one (if not soon into 2011 and the early test results have help to confirm Libi-Gel should be approved). The earnings call should be fine - the company has already publicly stated that cash at the end of the second quarter will be the same as it was at the end of Q-1. Tev-Tropin is doing great and Elestrin (which many had written off as a loser) will provide decent revenue now and into the future. The three analysts (and Michael Murphy) have come out with reports since the Anturol trial results and reaffirmed their buy ratings and targets (which are 100% above today's share price). AND as I keep saying, a new and exciting deal can come at any time. As for negatives which could drive us lower. Some speculate that the shelf registration could be used for a nearly immediate share sale and that would cause dilution. First I don't believe that will happen at anywhere near today's stock price, that it will happen anytime soon, and that if stock is sold - management will have a use for the money that will be highly beneficial to shareholders; and, on a worst case basis, if I am wrong the dilution is already discounted in the recent 25% drop in share price and there is nowhere to go but up....